Brendan O'Leary

US·SEC (Form 4)

Trius Therapeutics IncProtara Therapeutics, Inc.

Total declarations

Companies

▲ Purchases (1 ops.)

€656k

▼ Sales (0 ops.)

—

Latest filing published 29 Oct 2014 for Protara Therapeutics, Inc..

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

Closed purchases

Market purchases

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Protara Therapeutics, Inc. 1 purchase · last 29 Oct 2014

Since each purchase

Protara Therapeutics, Inc.
Filed 29 Oct 2014 · 4377 days ago · €656k
+51.2%
Entry US$421.68 · Close at T+365 US$637.60

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Brendan O'Leary: trading record in brief

This profile gathers the share dealings of Brendan O'Leary across 2 companies, led by Protara Therapeutics, Inc. and Trius Therapeutics Inc. Over a trading history stretching from 26 March 2012 to 27 October 2014, the count stands at 10 filings.

No open-market sale appears; the market trades are 1 purchase worth €656k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 2 option exercises. Since January 2014: 1 purchase and no sales on the market.

The newest entry dates from 29 October 2014: a transaction, in Protara Therapeutics, Inc. The last purchase on record was published on 29 October 2014, which is 4,377 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.